Volume 64, Issue 6, Pages (December 2013)

Slides:



Advertisements
Similar presentations
In biochemical recurrence after curative treatment of prostate cancer, Choline PET/CT 1- has a detection rate of 10-20% when PSA: 1-2 ng/ml 2- has a detection.
Advertisements

Volume 64, Issue 5, Pages (November 2013)
An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer  Marco Bandini, Giorgio Gandaglia, Nicola Fossati, Francesco.
Volume 69, Issue 11, Pages e435-e444 (November 2014)
Koray Şahin, MD, Serkan Bayram, MD, Ahmet Salduz, MD 
74-year-old man with stage T2a Gleason score prostate cancer (prostate specific antigen = ng/mL) in right transition zone (TZ) with history.
The PSA Era is not Over for Prostate Cancer
FDG PET-CT of Genitourinary and Gynecologic Tumors: Overcoming the Challenges of Evaluating the Abdomen and Pelvis  Leslie K. Lee, MD, Aoife Kilcoyne,
Volume 64, Issue 6, Pages (December 2013)
Volume 70, Issue 4, Pages (October 2016)
Whole-body diffusion-weighted magnetic resonance imaging: Current evidence in oncology and potential role in colorectal cancer staging  Doenja M.J. Lambregts,
Fig year-old male with left shoulder weakness after radiation therapy for metastatic lymph nodes in left supraclavicular area due to right lung.
Volume 70, Issue 5, Pages (November 2016)
Volume 56, Issue 6, Pages (December 2009)
Magnetic Resonance Imaging of Anorectal Neoplasms
Magnetic resonance imaging of less common pancreatic malignancies and pancreatic tumors with malignant potential  D. Franz, I. Esposito, A.-C. Kapp, J.
Volume 62, Issue 5, Pages (November 2012)
Mapping of Pelvic Lymph Node Metastases in Prostate Cancer
Potential and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in Kidney, Prostate, and Bladder Cancer Including Pelvic Lymph Node Staging:
Volume 199, Issue 1, Pages (January 2018)
Pelvic Applications of Diffusion Magnetic Resonance Images
Volume 67, Issue 3, Pages (March 2015)
Volume 62, Issue 2, Pages (August 2012)
Volume 71, Issue 1, Pages (January 2017)
Volume 70, Issue 5, Pages (November 2016)
Volume 64, Issue 6, Pages (December 2013)
Preliminary experience with superparamagnetic iron oxide-enhanced dynamic magnetic resonance imaging and comparison with contrast-enhanced computed tomography.
Volume 55, Issue 4, Pages (April 2009)
Diagnostic Value of MRI in a Pelvic Mass of Prostatic Origin
Locally advanced rectal cancer: Qualitative and quantitative evaluation of diffusion- weighted MR imaging in the response assessment after neoadjuvant.
Dynamic Contrast-Enhanced MRI for Preoperative Identification of Localised Prostate Cancer  Arnauld Villers, Philippe Puech, Xavier Leroy, Jacques Biserte,
Inflammatory Pseudotumours in the Abdomen and Pelvis: A Pictorial Essay  Tony Sedlic, MD, Elena P. Scali, MD, Wai-Kit Lee, MD, Sadhna Verma, MD, Silvia.
Volume 61, Issue 3, Pages (March 2012)
Imaging of Perianal Fistulas
Volume 72, Issue 3, Pages (September 2017)
Volume 70, Issue 4, Pages (October 2016)
Volume 64, Issue 5, Pages (November 2013)
Angelo J. Cambio, Christopher P. Evans  European Urology 
Volume 59, Issue 3, Pages (March 2011)
Assessing the validity of Prostate Imaging Reporting and Data System version 2 (PI- RADS v2) scoring system in diagnosis of peripheral zone prostate cancer 
Prostate MRI: The Hemorrhage Exclusion Sign
Volume 62, Issue 1, Pages (July 2012)
Volume 57, Issue 2, Pages (February 2010)
Volume 67, Issue 4, Pages (April 2015)
Robotic-Assisted Laparoscopic Radical Cystoprostatectomy
Volume 59, Issue 6, Pages (June 2011)
The PSA Era is not Over for Prostate Cancer
European Urology Oncology
Volume 53, Issue 3, Pages (March 2008)
Radical Perineal Prostatectomy and Simultaneous Extended Pelvic Lymph Node Dissection via the Same Incision  Hansjörg Keller, Joachim Lehmann, Jörn Beier 
Volume 65, Issue 4, Pages (April 2014)
Volume 68, Issue 6, Pages (December 2015)
Functional imaging in liver tumours
Diffusion Magnetic Resonance Imaging in the Head and Neck
Volume 53, Issue 1, Pages (January 2008)
Staging of pelvic lymph nodes in patients with prostate cancer: Usefulness of multiple b value SE-EPI diffusion-weighted imaging on a 3.0T MR system 
Alexey Surov, MD, Michael Hainz, MD, Malte Kornhuber, MD 
A 40-Year-Old Woman With Back Pain
Volume 64, Issue 1, Pages (July 2003)
Volume 66, Issue 6, Pages (December 2014)
Images from the case of a 34-year-old woman with an enlarging mass on the right side of her neck. Images from the case of a 34-year-old woman with an enlarging.
MR-PET of the body: Early experience and insights
Improved characterization of popliteal aneurysms using gadofosveset-enhanced equilibrium phase magnetic resonance angiography  Mauricio S. Galizia, MD,
Volume 69, Issue 1, Pages (January 2016)
Volume 54, Issue 2, Pages (August 2008)
Volume 52, Issue 2, Pages (August 2007)
Journal of Vascular Surgery
Volume 4, Issue 1, Pages (February 2006)
Magnetic Resonance Angiography and Detection of Renal Artery Stenosis in a Patient With Impaired Renal Function  EMANUEL FARRUGIA, M.D.  Mayo Clinic Proceedings 
Volume 54, Issue 1, Pages (July 2008)
Presentation transcript:

Volume 64, Issue 6, Pages 953-960 (December 2013) Combined Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced and Diffusion-weighted Magnetic Resonance Imaging Facilitates Detection of Metastases in Normal-sized Pelvic Lymph Nodes of Patients with Bladder and Prostate Cancer  Frédéric D. Birkhäuser, Urs E. Studer, Johannes M. Froehlich, Maria Triantafyllou, Lauren J. Bains, Giuseppe Petralia, Peter Vermathen, Achim Fleischmann, Harriet C. Thoeny  European Urology  Volume 64, Issue 6, Pages 953-960 (December 2013) DOI: 10.1016/j.eururo.2013.07.032 Copyright © 2013 European Association of Urology Terms and Conditions

Fig. 1 Schematic diagram of the functional principle of combined ultrasmall superparamagnetic particles of iron oxide (USPIOs), diffusion-weighted (DW) magnetic resonance imaging (MRI). After intravenous injection, USPIOs are transported through the vascular endothelium into the interstitial space. The USPIOs are taken up by macrophages and subsequently transported into healthy lymph nodes (LNs). The iron oxide crystalline core of the USPIO produces strong susceptibility leading to a signal decrease on T2- or T2*-weighted MRI. This signal decrease can be used to identify healthy LNs, which contain significant amounts of USPIO within the macrophages and appear hypointense. Malignant LNs, in contrast, have few macrophages and are characterised by a total or partial lack of USPIO uptake, depending on the degree of macrophage displacement, and they do not show a change in signal intensity after USPIO injection. The lack of USPIO uptake in metastatic LNs, therefore, acts as a positive contrast agent highlighting and potentially facilitating the identification of metastases in normal-sized LNs, even those the size of a single magnetic resonance voxel. In addition, malignant LNs appear hyperintense on high b-value DW-MRI due to the restriction of extracellular water diffusion in metastatic regions with increased cellular density. Thus metastatic LNs can be characterised by a high signal intensity on DW-MRI and a lack of signal decrease following USPIO injection. European Urology 2013 64, 953-960DOI: (10.1016/j.eururo.2013.07.032) Copyright © 2013 European Association of Urology Terms and Conditions

Fig. 2 Magnetic resonance image of a metastatic lymph node (LN) with histopathologic correlation. These images, from a 48-yr-old man with muscle-invasive bladder cancer stage pT3a pN2 G3, show the typical order of reading: (A) axial diffusion-weighted (DW) magnetic resonance imaging (MRI) at a b-value of 1000 s/mm2 24h after administration of ultrasmall superparamagnetic particles of iron oxide (USPIOs; combined USPIO-DW-MRI) showing a hyperintense, focal, noncontinuous round structure (arrow) in the left internal iliac region that is suspicious due to the lack of USPIO uptake. (B) Axial, reconstructed, T2-weighted image shows the suspicious LN on the left side (arrow) measuring 7×6mm. (C) Parasagittally reconstructed, T1-weighted, fat-saturated image after USPIO administration shows the localisation of the left suspicious LN (arrow) between the internal and external iliac arteries. (D) Histopathologic analysis of the dissected LN (8×5mm) stained with haematoxylin-eosin. #=LN metastases measuring 7×4mm; *=lymphoreticular tissue. European Urology 2013 64, 953-960DOI: (10.1016/j.eururo.2013.07.032) Copyright © 2013 European Association of Urology Terms and Conditions

Fig. 3 Magnetic resonance image of a metastatic and a benign lymph node (LN) with histopathologic correlation. The patient was a 67-yr-old man with prostate cancer stage pT4 (bladder neck) pN1, Gleason score 10, preoperative prostate-specific antigen level of 3.7μg/ml. (A) Axial diffusion-weighted (DW) magnetic resonance imaging (MRI) at a b-value of 1000 s/mm2 24h after administration of ultrasmall superparamagnetic particles of iron oxide (USPIOs; combined USPIO-DW-MRI) shows a suspicious hyperintense structure (arrow) on the left pelvic side posterior to the external iliac vessels. The LN on the right pelvic side is not visible (arrowhead) due to signal loss in normal LNs following USPIO uptake. Note that the posterior bilateral hyperintense structures correspond to sacral nerve roots. (B) Axially reconstructed T2-weighted image shows the suspicious LN on the left side (arrow) measuring 10×7mm and a normal LN on the right side (arrowhead) measuring 5×4mm. (C) Parasagittally reconstructed T2-weighted image shows the suspicious LN located posterior to the left external iliac artery. (D) Histopathologic analysis of the dissected LN (5×4.5mm) stained with haematoxylin-eosin. #=LN metastases measuring 5×4mm; *=lymphoreticular tissue. European Urology 2013 64, 953-960DOI: (10.1016/j.eururo.2013.07.032) Copyright © 2013 European Association of Urology Terms and Conditions